These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 7019188)

  • 1. Renal elimination of cefoxitin and effect of probenecid after single and repeated doses.
    Arvidsson A; Borgå O; Kager L; Pieper R
    J Antimicrob Chemother; 1981 Apr; 7(4):423-30. PubMed ID: 7019188
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of orally administered probenecid on the pharmacokinetics of cefoxitin.
    Vlasses PH; Holbrook AM; Schrogie JJ; Rogers JD; Ferguson RK; Abrams WB
    Antimicrob Agents Chemother; 1980 May; 17(5):847-55. PubMed ID: 7396472
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of probenecid on the pharmacokinetics and distribution of cefoxitin in healthy volunteers.
    Reeves DS; Bullock DW; Bywater MJ; Holt HA; White LO; Thornhill DP
    Br J Clin Pharmacol; 1981 Apr; 11(4):353-9. PubMed ID: 7259928
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of intravenously administered cefmetazole and cefoxitin and effects of probenecid on cefmetazole elimination.
    Ko H; Cathcart KS; Griffith DL; Peters GR; Adams WJ
    Antimicrob Agents Chemother; 1989 Mar; 33(3):356-61. PubMed ID: 2729930
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of probenecid on gentamycin pharmacokinetics.
    Bergan T; Westlie L; Brodwall EK
    Acta Med Scand; 1972 Mar; 191(3):221-4. PubMed ID: 5033712
    [No Abstract]   [Full Text] [Related]  

  • 6. Pleural fluid levels of cefoxitin in patients with renal impairment.
    Barrueco M; Otero MJ; Garcia MJ; Lanao JM; Dominguez-Gil A
    Int J Clin Pharmacol Ther Toxicol; 1986 Sep; 24(9):485-9. PubMed ID: 3781682
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Observations on the disposition of probenecid in patients receiving allopurinol.
    Tjandramaga TB; Cucinell SA; Israili ZH; Perel JM; Dayton PG; Yü TF; Gutman AB
    Pharmacology; 1972; 8(4):259-72. PubMed ID: 4572009
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of probenecid on serum cefoxitin concentrations.
    Bint AJ; Reeves DS; Holt HA
    J Antimicrob Chemother; 1977 Nov; 3(6):627-8. PubMed ID: 599129
    [No Abstract]   [Full Text] [Related]  

  • 9. Bioavailability and pharmacokinetics of cefoxitin sodium.
    Schrogie JJ; Davies RO; Yeh KC; Rogers D; Holmes GI; Skeggs H; Martin CM
    J Antimicrob Chemother; 1978 Jul; 4(B):69-78. PubMed ID: 99418
    [No Abstract]   [Full Text] [Related]  

  • 10. Cinoxacin: pharmacokinetics and the effect of probenecid.
    Israel KS; Black HR; Nelson RL; Brunson MK; Nash JF; Brier GL; Wolney JD
    J Clin Pharmacol; 1978 Oct; 18(10):491-9. PubMed ID: 711932
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of acute renal impairment in the penetration of cefoxitin into interstitial tissue fluid in rabbits.
    Dominguez-Gil AA; Garcia MJ; Cepeda M; Lanao JM; Dominguez-Gil A
    Clin Ther; 1981; 3(6):413-24. PubMed ID: 7260987
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of probenecid on renal elimination of cefoxitin.
    Thornhill DP; Reeves DS
    J Antimicrob Chemother; 1981 Nov; 8(5):421-2. PubMed ID: 7319982
    [No Abstract]   [Full Text] [Related]  

  • 13. No effect of probenecid on the renal and biliary clearances of digoxin in man.
    Hedman A; Angelin B; Arvidsson A; Dahlqvist R
    Br J Clin Pharmacol; 1991 Jul; 32(1):63-7. PubMed ID: 1888643
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of probenecid on renal clearance of riboflavin in man.
    Jusko WJ; Levy G; Yaffe SJ; Gorodischer R
    J Pharm Sci; 1970 Apr; 59(4):473-7. PubMed ID: 5440673
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of probenecid on the distribution and elimination of ciprofloxacin in humans.
    Jaehde U; Sörgel F; Reiter A; Sigl G; Naber KG; Schunack W
    Clin Pharmacol Ther; 1995 Nov; 58(5):532-41. PubMed ID: 7586947
    [TBL] [Abstract][Full Text] [Related]  

  • 16. No effect of probenecid on the renal excretion mechanism of a new carbapenem, DA-1131, in dogs.
    Kim SH; Kim WB; Lee MG
    Res Commun Mol Pathol Pharmacol; 1998 Jul; 101(1):85-92. PubMed ID: 9755846
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of cefoxitin in patients with pleural effusion on a multiple dosage regimen.
    Garcia MJ; Otero MJ; Barrueco M; Dominguez-Gil A
    Int J Clin Pharmacol Ther Toxicol; 1984 Jun; 22(6):300-3. PubMed ID: 6746153
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypouricemia due to renal tubular defect. A study with the probenecid-pyrazinamide test.
    Smetana SS; Bar-Khayim Y
    Arch Intern Med; 1985 Jul; 145(7):1200-3. PubMed ID: 4015266
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of probenecid on furosemide kinetics and natriuresis in man.
    Honari J; Blair AD; Cutler RE
    Clin Pharmacol Ther; 1977 Oct; 22(4):395-401. PubMed ID: 902452
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of cefoxitin administered intramuscularly to rabbits with experimentally-induced renal impairment.
    Garcia MJ; Dominguez-Gil AA; Cepeda M; Dominguez-Gil A
    Biopharm Drug Dispos; 1981; 2(3):205-13. PubMed ID: 7295878
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.